AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

13,578.00p
   
  • Change Today:
    -14.00p
  • 52 Week High: 14,148.00p
  • 52 Week Low: 9,667.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.73m
  • Volume: 3,865,312
  • Market Cap: £210,558m
  • RiskGrade: 123

Latest Deals

Traded Action Notifier PriceAmountValue
12-Nov-25 Sell Aradhana Sarin 6,748.89p 15,000 £1,012,333.20

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
12-Nov-25 Sell Aradhana Sarin 6,748.89p 15,000 £1,012,333.20

Director Shareholdings

Notifier Holding Value*
Pascal Soriot 746,354 £101,339,946
Aradhana Sarin 93,804 £12,736,707
Marcus Wallenberg 60,028 £8,150,602
Michel Demare 10,000 £1,357,800
Philip A J Broadley 8,025 £1,089,634
Tony Mok 3,500 £475,230
Sheri McCoy 1,736 £235,714
Karen Knudsen 1,405 £190,771
Diana Layfield 1,400 £190,092
Euan Ashley 1,150 £156,147
Nazneen Rahman 1,017 £138,088
Anna Manz 487 £66,125

Major Shareholders

Notifier** Holding Value*
BlackRock, Inc 100,885,181 £13,698,189,876
Oddo Meriten Asset Management SA 100,885,181 £13,698,189,876
The Capital Group Companies, Inc. 77,125,348 £10,472,079,751
Wellington Management Company LLP 65,118,411 £8,841,777,846
Investor AB 51,587,810 £7,004,592,842

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 13,578.00p
Change Today -14.00p
% Change -0.10 %
52 Week High 14,148.00p
52 Week Low 9,667.00p
Volume 3,865,312
Shares Issued 1,550.73m
Market Cap £210,558m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 3
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for 08-Dec-2025

Time Volume / Share Price
16:22 0 @ 13,564.00p
16:22 0 @ 13,566.00p
15:47 0 @ 13,538.00p
15:59 0 @ 13,516.00p
15:22 0 @ 13,524.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page